Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 152 for “"antisense oligonucleotide"”.

  1. Predicting Antisense Oligonucleotide Thermodynamics using Deep Learning

    Antisense oligonucleotides (ASOs) have emerged as a promising approach in medicine for the treatment of diseases associated with disrupted protein production. However, the lengthy drug discovery process poses a significant challenge. This project aimed to address this challenge by developing a …

    chalmers Repository record for Predicting Antisense Oligonucleotide Thermodynamics using Deep Learning (opens in a new tab)

  2. Delivery and stability of antisense oligonucleotide conjugates in vitro

    The efficacy of antisense oligonucleotide (ODN) therapy is dependent on four major parameters: delivery to cells, intracellular stability and localisation and efficient action at the target site.The aim of this project was to study the delivery of ODNs to macrophages and to assess the stability of …

    aston Download PDF for Delivery and stability of antisense oligonucleotide conjugates in vitro (opens in a new tab)

  3. Antisense Oligonucleotide-Loaded Liposomes for Gene Silencing in Bacterial Biofilms

    … of cationic liposomes encapsulated with antisense oligonucleotides. The liposomes themselves were synthesized via a microfluidic system to ensure uniform particle size distribution conducive to bacterial biofilm uptake. Furthermore, the various liposome samples exhibited favourable …

    waterloo Repository record for Antisense Oligonucleotide-Loaded Liposomes for Gene Silencing in Bacterial Biofilms (opens in a new tab)

  4. ENHANCE ROBUSTNESS OF DETRITYLATION STEP IN SOLID PHASE ANTISENSE OLIGONUCLEOTIDE SYNTHESIS

    Antisense Oligonucleotide (ASO) based drugs are now novel and promising therapeutics for treating a large variety of diseases. ASOs are single strand short nucleotides that are typically 15-25 nucleotides long. They target mRNAs instead of normal protein receptors and bring therapeutic …

    jhu Repository record for ENHANCE ROBUSTNESS OF DETRITYLATION STEP IN SOLID PHASE ANTISENSE OLIGONUCLEOTIDE SYNTHESIS (opens in a new tab) Embargoed until 2027-08-01

  5. Down-regulation of central glucocorticoid receptor expression using antisense oligonucleotide technology

    … in vitro and in vivo, with empirically-designed antisense oligodeoxynucleotides (ODN), to characterise GR modulation of 5-HT2A receptor expression using quantitative RT-PCR, Western blot analysis and radioligand binding. The functional consequence of GR downregulation is also determined by …

    aston Download PDF for Down-regulation of central glucocorticoid receptor expression using antisense oligonucleotide technology (opens in a new tab)

  6. Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene

    Duchene Muscular Dystrophy (DMD), and the milder allelic Becker muscular dystrophy (EMD), are X-linked recessive muscle wasting disorders characterised by mutations in the dystrophin gene. DMD occurs at a frequency of approximately 1 in 3500 male newborns and life expectancy is typically less than …

    edithcowan Repository record for Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene (opens in a new tab)

  7. Liposome encapsulation enhances the anti-inflammatory activity of an ICAM-1 antisense oligonucleotide

    Antisense oligonucleotides are designed to specifically bind to a variety of DNA and RNA targets to inhibit the translation of the genetic code into protein. By targeting disease-associated proteins this technology offers the potential for rapid design of highly specific drugs. However, the …

    ubc Repository record for Liposome encapsulation enhances the anti-inflammatory activity of an ICAM-1 antisense oligonucleotide (opens in a new tab) Download PDF for Liposome encapsulation enhances the anti-inflammatory activity of an ICAM-1 antisense oligonucleotide (opens in a new tab)

  8. Molecular and preclinical aspects of antisense oligonucleotide treatment for myotonic dystrophy type 1

    … Currently, there is no cure available for DM1. Antisense oligonucleotides (AONs) complementary to the (CUG)n repeat constitute a promising tool for treatment of DM1. We performed a broad screening of chemically modified (CAG)n AONs for their ability to reduce expanded DMPK mRNA levels. We found …

    radboud Repository record for Molecular and preclinical aspects of antisense oligonucleotide treatment for myotonic dystrophy type 1 (opens in a new tab) Download PDF for Molecular and preclinical aspects of antisense oligonucleotide treatment for myotonic dystrophy type 1 (opens in a new tab)

  9. EXPLORING ANTISENSE OLIGONUCLEOTIDE THERAPY TARGETING PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE S IN C9ORF72-ALS/FTD

    … cause of ALS and FTD. Translation of sense and antisense G4C2 repeat expansion produces neurotoxic dipeptide repeat (DPR) proteins. Among the various dipeptide repeat proteins, poly-GR and PR are relatively more toxic to neurons, positioning poly-GR and PR as a potential target to mitigate …

    jhu Repository record for EXPLORING ANTISENSE OLIGONUCLEOTIDE THERAPY TARGETING PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE S IN C9ORF72-ALS/FTD (opens in a new tab)

  10. Prevention of influenza viral pneumonia using zanamivir and antisense oligonucleotide against inducible nitric oxide synthase /

    … of this study - to evaluate if zanamivir and/or antisense oligonucleotide against inducible nitric oxide synthase prevents influenza viral pneumonia. During the experiment, the mice were infected with the influenza virus and treated with zanamivir, antisense oligonucleotide against iNOS or a …

    vilnius Repository record for Prevention of influenza viral pneumonia using zanamivir and antisense oligonucleotide against inducible nitric oxide synthase / (opens in a new tab)

  11. Investigating the Effect of miR-145-5p Inhibition with an Antisense Oligonucleotide on Experimental Autoimmune Encephalomyelitis

    … to determine if inhibition of miR-145-5p with an antisense oligonucleotide (ASO) is sufficient to protect mice from EAE. Female mice were induced with EAE and then treated with a control or miR-145 ASO at the onset of disease. We evaluated disease progression by monitoring clinical severity, and …

    ottawa-retro Repository record for Investigating the Effect of miR-145-5p Inhibition with an Antisense Oligonucleotide on Experimental Autoimmune Encephalomyelitis (opens in a new tab)

  12. Identification of Antisense Oligonucleotide Internalization and Transport by Scavenging Receptor Proteins in Liver Sinusoidal Endothelial Cells

    Antisense Oligonucleotides (ASOs) are an emerging field of gene therapeutics. These drugs are small DNA/RNA hybrid nucleoside polymers that modulate mRNA levels of targets identified in the progression of the specific disease. ASOs have multiple mechanisms and chemistries that may be utilized, with …

    nebraska Repository record for Identification of Antisense Oligonucleotide Internalization and Transport by Scavenging Receptor Proteins in Liver Sinusoidal Endothelial Cells (opens in a new tab)

  13. An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors

    … delivery of both phosphorothioated clusterin antisense oligonucleotide (clusterin ASO) and paclitaxel or docetaxel to prostate tumors to maintain therapeutic concentrations of the agents at the target disease site was investigated in this work. The primary objectives were to develop and …

    ubc Repository record for An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors (opens in a new tab) Download PDF for An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors (opens in a new tab)

  14. An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors

    Surgical procedures performed on blood vessels may cause irritation of the vessel wall. This irritation sets off a series of complicated steps, which results in a growth of the vessel wall towards the center of the blood vessel, and a narrowing of the amount of space for the blood to flow through. …

    ubc Repository record for An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors (opens in a new tab) Download PDF for An intratumoral controlled release formulation of clusterin antisense oligonucleotide and paclitaxel or docetaxel for treatment of prostate tumors (opens in a new tab)

  15. Characterization of an antisense oligonucleotide targeted at Phospholipase C gamma 1 in the mouse T-cell line EL4.1L-2

    … Therefore, in this study, we characterized an antisense oligonucleotide (ASO) against PLCgamma1 and study its effect on T cell activation. ASOs complementary to mouse PLCgamma1 mRNA were designed and screened in the mouse T cell line, EL4.IL-2. Among all, ASO3 showed the highest PLCgamma1 …

    nus Repository record for Characterization of an antisense oligonucleotide targeted at Phospholipase C gamma 1 in the mouse T-cell line EL4.1L-2 (opens in a new tab) Download file for Characterization of an antisense oligonucleotide targeted at Phospholipase C gamma 1 in the mouse T-cell line EL4.1L-2 (opens in a new tab)

  16. A study of a murine model of Aristolochic Acid Nephropathy and the impact of Antisense Oligonucleotide therapy targeting Kras

    … then used to target Kras transcription with an Antisense Oligonucleotide (ASO) in the peri AKI period with the aim of reducing downstream fibrosis. <br/>CD1 mice were given two doses of 3.5mg/kg Aristolochic Acid via intraperitoneal injections, the first on Day 1 and the second on Day 5. The …

    kings Repository record for A study of a murine model of Aristolochic Acid Nephropathy and the impact of Antisense Oligonucleotide therapy targeting Kras (opens in a new tab)

Page 1 of 8